1
ARGENX SE
SPONSORED ADR
ARGX
ARGX
400,000
$151.6m8.43%
8.43%
Reduced Shares held: Q3 2021 577.3k, Q4 2021 500.0k, Q1 2022 587.5k, Q2 2022 400.0k
-187.5k
-187,500
-31.9%
2
LEXICON PHARMACEUTICALS INC
COM NEW
LXRX
LXRX
71,178,364
$132.4m7.36%
7.36%
Unchanged Shares held: Q3 2021 71.2m, Q4 2021 71.2m, Q1 2022 71.2m, Q2 2022 71.2m
3
BEIGENE LTD
SPONSORED ADR
ONC
ONC
650,000
$105.2m5.85%
5.85%
Reduced Shares held: Q3 2021 650.0k, Q4 2021 675.0k, Q1 2022 665.0k, Q2 2022 650.0k
-15.0k
-15,000
-2.3%
4
WW INTL INC
COM
WTW
WTW
14,818,300
$94.7m5.27%
5.27%
Unchanged Shares held: Q3 2021 14.8m, Q4 2021 14.8m, Q1 2022 14.8m, Q2 2022 14.8m
5
SEAGEN INC
COM
SGEN
SGEN
525,000
$92.9m5.17%
5.17%
Reduced Shares held: Q3 2021 375.0k, Q4 2021 500.0k, Q1 2022 650.0k, Q2 2022 525.0k
-125.0k
-125,000
-19.2%
6
ALNYLAM PHARMACEUTICALS INC
COM
ALNY
ALNY
600,000
$87.5m4.87%
4.87%
Reduced Shares held: Q3 2021 700.0k, Q4 2021 650.0k, Q1 2022 650.0k, Q2 2022 600.0k
-50.0k
-50,000
-7.7%
7
MIRATI THERAPEUTICS INC
COM
MRTX
MRTX
1,100,000
$73.8m4.11%
4.11%
Reduced Shares held: Q3 2021 1.2m, Q4 2021 1.4m, Q1 2022 1.4m, Q2 2022 1.1m
-250.0k
-250,000
-18.5%
8
BELLUS HEALTH INC NEW
COM NEW
BLU
BLU
7,000,000
$64.7m3.60%
3.60%
Reduced Shares held: Q3 2021 5.2m, Q4 2021 8.5m, Q1 2022 8.5m, Q2 2022 7.0m
-1.5m
-1,500,000
-17.6%
9
FATE THERAPEUTICS INC
COM
FATE
FATE
2,600,000
$64.4m3.58%
3.58%
Added Shares held: Q3 2021 1.4m, Q4 2021 1.8m, Q1 2022 2.0m, Q2 2022 2.6m
+600.0k
+600,000
30.0%
10
CYTOKINETICS INC
COM NEW
CYTK
CYTK
1,275,000
$50.1m2.79%
2.79%
Added Shares held: Q3 2021 1.3m, Q4 2021 1.0m, Q1 2022 1.0m, Q2 2022 1.3m
+275.0k
+275,000
27.5%
11
SCHOLAR ROCK HLDG CORP
COM
SRRK
SRRK
8,750,034
$48.0m2.67%
2.67%
Added Shares held: Q3 2021 1.9m, Q4 2021 2.5m, Q1 2022 2.5m, Q2 2022 8.8m
+6.3m
+6,300,034
257.1%
12
AMICUS THERAPEUTICS INC
COM
FOLD
FOLD
4,000,000
$43.0m2.39%
2.39%
Unchanged Shares held: Q3 2021 6.7m, Q4 2021 6.0m, Q1 2022 4.0m, Q2 2022 4.0m
13
SEER INC
COM CL A
SEER
SEER
4,750,000
$42.5m2.36%
2.36%
Unchanged Shares held: Q3 2021 4.8m, Q4 2021 4.8m, Q1 2022 4.8m, Q2 2022 4.8m
14
CEREVEL THERAPEUTICS HLDNG I
COM
CERE
CERE
1,500,000
$39.7m2.21%
2.21%
Unchanged Shares held: Q3 2021 1.8m, Q4 2021 1.5m, Q1 2022 1.5m, Q2 2022 1.5m
15
IGM BIOSCIENCES INC
COM
IGMS
IGMS
2,000,000
$36.1m2.01%
2.01%
Unchanged Shares held: Q3 2021 1.4m, Q4 2021 1.5m, Q1 2022 2.0m, Q2 2022 2.0m
16
MORPHIC HLDG INC
COM
MORF
MORF
1,650,000
$35.8m1.99%
1.99%
Unchanged Shares held: Q3 2021 1.6m, Q4 2021 1.6m, Q1 2022 1.6m, Q2 2022 1.6m
17
KRYSTAL BIOTECH INC
COM
KRYS
KRYS
500,000
$32.8m1.83%
1.83%
Unchanged Shares held: Q3 2021 500.0k, Q4 2021 700.0k, Q1 2022 500.0k, Q2 2022 500.0k
18
FOGHORN THERAPEUTICS INC
COM
FHTX
FHTX
1,720,720
$23.4m1.30%
1.30%
Unchanged Shares held: Q3 2021 1.7m, Q4 2021 1.7m, Q1 2022 1.7m, Q2 2022 1.7m
19
SPRINGWORKS THERAPEUTICS INC
COM
SWTX
SWTX
900,000
$22.2m1.23%
1.23%
Added Shares held: Q3 2021 600.0k, Q4 2021 850.0k, Q1 2022 850.0k, Q2 2022 900.0k
+50.0k
+50,000
5.9%
20
GOSSAMER BIO INC
COM
GOSS
GOSS
2,358,968
$19.7m1.10%
1.10%
Unchanged Shares held: Q3 2021 2.4m, Q4 2021 2.4m, Q1 2022 2.4m, Q2 2022 2.4m
21
KYMERA THERAPEUTICS INC
COM
KYMR
KYMR
1,000,000
$19.7m1.09%
1.09%
Unchanged Shares held: Q3 2021 400.0k, Q4 2021 1.0m, Q1 2022 1.0m, Q2 2022 1.0m
22
KURA ONCOLOGY INC
COM
KURA
KURA
1,050,000
$19.2m1.07%
1.07%
Unchanged Shares held: Q3 2021 1.1m, Q4 2021 1.1m, Q1 2022 1.1m, Q2 2022 1.1m
23
EQRX INC
COM
COM
4,000,000
$18.8m1.04%
1.04%
Unchanged Shares held: Q3 2021 0, Q4 2021 4.0m, Q1 2022 4.0m, Q2 2022 4.0m
24
SCHRODINGER INC
COM
SDGR
SDGR
700,000
$18.5m1.03%
1.03%
Unchanged Shares held: Q3 2021 700.0k, Q4 2021 700.0k, Q1 2022 700.0k, Q2 2022 700.0k
25
GENERATION BIO CO
COM
COM
2,814,191
$18.5m1.03%
1.03%
Unchanged Shares held: Q3 2021 2.8m, Q4 2021 2.8m, Q1 2022 2.8m, Q2 2022 2.8m
26
ERASCA INC
COM
ERAS
ERAS
3,172,221
$17.7m0.98%
0.98%
Unchanged Shares held: Q3 2021 3.2m, Q4 2021 3.2m, Q1 2022 3.2m, Q2 2022 3.2m
27
DENALI THERAPEUTICS INC
COM
DNLI
DNLI
600,000
$17.7m0.98%
0.98%
Unchanged Shares held: Q3 2021 500.0k, Q4 2021 600.0k, Q1 2022 600.0k, Q2 2022 600.0k
28
REPLIMUNE GROUP INC
COM
REPL
REPL
900,000
$15.7m0.87%
0.87%
Unchanged Shares held: Q3 2021 900.0k, Q4 2021 900.0k, Q1 2022 900.0k, Q2 2022 900.0k
29
SAGE THERAPEUTICS INC
COM
SAGE
SAGE
450,000
$14.5m0.81%
0.81%
Reduced Shares held: Q3 2021 1.0m, Q4 2021 1.0m, Q1 2022 750.0k, Q2 2022 450.0k
-300.0k
-300,000
-40.0%
30
INTELLIA THERAPEUTICS INC
COM
NTLA
NTLA
275,000
$14.2m0.79%
0.79%
Unchanged Shares held: Q3 2021 275.0k, Q4 2021 275.0k, Q1 2022 275.0k, Q2 2022 275.0k
31
EVOTEC AG
SPONSORED ADS
EVO
EVO
1,149,425
$13.8m0.77%
0.77%
Unchanged Shares held: Q3 2021 0, Q4 2021 1.1m, Q1 2022 1.1m, Q2 2022 1.1m
32
RELAY THERAPEUTICS INC
COM
RLAY
RLAY
700,000
$11.7m0.65%
0.65%
Unchanged Shares held: Q3 2021 400.0k, Q4 2021 750.0k, Q1 2022 700.0k, Q2 2022 700.0k
33
MERSANA THERAPEUTICS INC
COM
COM
2,200,000
$10.2m0.57%
0.57%
Unchanged Shares held: Q3 2021 1.2m, Q4 2021 1.2m, Q1 2022 2.2m, Q2 2022 2.2m
34
AURINIA PHARMACEUTICALS INC
COM
AUPH
AUPH
1,000,000
$10.1m0.56%
0.56%
Unchanged Shares held: Q3 2021 1.0m, Q4 2021 1.0m, Q1 2022 1.0m, Q2 2022 1.0m
35
REPARE THERAPEUTICS INC
COM
RPTX
RPTX
700,000
$9.8m0.54%
0.54%
Unchanged Shares held: Q3 2021 550.0k, Q4 2021 700.0k, Q1 2022 700.0k, Q2 2022 700.0k
36
WAVE LIFE SCIENCES LTD
SHS
96663EUR
96663EUR
3,000,000
$9.8m0.54%
0.54%
Added Shares held: Q3 2021 1.0m, Q4 2021 1.0m, Q1 2022 1.0m, Q2 2022 3.0m
+2.0m
+2,000,000
200.0%
37
I MAB
SPONSORED ADS
NBP
NBP
850,000
$9.6m0.53%
0.53%
Unchanged Shares held: Q3 2021 825.0k, Q4 2021 850.0k, Q1 2022 850.0k, Q2 2022 850.0k
38
TALARIS THERAPEUTICS INC
COM
COM
2,064,262
$9.3m0.52%
0.52%
Unchanged Shares held: Q3 2021 2.1m, Q4 2021 2.1m, Q1 2022 2.1m, Q2 2022 2.1m
39
ALLOVIR INC
COM
COM
2,323,371
$9.1m0.50%
0.50%
Unchanged Shares held: Q3 2021 2.3m, Q4 2021 2.3m, Q1 2022 2.3m, Q2 2022 2.3m
40
OMEGA THERAPEUTICS INC
COMMON STOCK
COMMON STOCK
2,273,530
$8.6m0.48%
0.48%
Unchanged Shares held: Q3 2021 2.3m, Q4 2021 2.3m, Q1 2022 2.3m, Q2 2022 2.3m
41
ITEOS THERAPEUTICS INC
COM
ITOS
ITOS
400,000
$8.2m0.46%
0.46%
Unchanged Shares held: Q3 2021 994.0k, Q4 2021 544.0k, Q1 2022 400.0k, Q2 2022 400.0k
42
ATARA BIOTHERAPEUTICS INC
COM
COM
1,000,000
$7.8m0.43%
0.43%
Unchanged Shares held: Q3 2021 1.5m, Q4 2021 1.5m, Q1 2022 1.0m, Q2 2022 1.0m
43
OMEGA ALPHA SPAC
CL A
CL A
750,000
$7.4m0.41%
0.41%
Unchanged Shares held: Q3 2021 750.0k, Q4 2021 750.0k, Q1 2022 750.0k, Q2 2022 750.0k
44
IKENA ONCOLOGY INC
COM
COM
1,549,513
$6.9m0.38%
0.38%
Unchanged Shares held: Q3 2021 1.5m, Q4 2021 1.5m, Q1 2022 1.5m, Q2 2022 1.5m
45
SELECTA BIOSCIENCES INC
COM
COM
4,883,200
$6.4m0.36%
0.36%
Added Shares held: Q3 2021 4.0m, Q4 2021 4.0m, Q1 2022 4.0m, Q2 2022 4.9m
+883.2k
+883,200
22.1%
46
VERVE THERAPEUTICS INC
COM
COM
400,000
$6.1m0.34%
0.34%
Unchanged Shares held: Q3 2021 400.0k, Q4 2021 400.0k, Q1 2022 400.0k, Q2 2022 400.0k
47
Y-MABS THERAPEUTICS INC
COM
YMAB
YMAB
400,000
$6.1m0.34%
0.34%
Unchanged Shares held: Q3 2021 400.0k, Q4 2021 400.0k, Q1 2022 400.0k, Q2 2022 400.0k
48
EXSCIENTIA PLC
ADS
EXAI
EXAI
550,000
$6.0m0.33%
0.33%
Unchanged Shares held: Q3 2021 0, Q4 2021 550.0k, Q1 2022 550.0k, Q2 2022 550.0k
49
AGENUS INC
COM NEW
COM NEW
3,000,000
$5.8m0.32%
0.32%
Reduced Shares held: Q3 2021 5.5m, Q4 2021 6.5m, Q1 2022 5.5m, Q2 2022 3.0m
-2.5m
-2,500,000
-45.5%
50
AMBRX BIOPHARMA INC
SPONSORED ADS
SPONSORED ADS
2,152,291
$5.7m0.32%
0.32%
Unchanged Shares held: Q3 2021 850.0k, Q4 2021 2.2m, Q1 2022 2.2m, Q2 2022 2.2m
51
ACHILLES THERAPEUTICS PLC
SPONSORED ADS
SPONSORED ADS
2,255,375
$5.7m0.32%
0.32%
Unchanged Shares held: Q3 2021 2.3m, Q4 2021 2.3m, Q1 2022 2.3m, Q2 2022 2.3m
52
KRONOS BIO INC
COM
KRON
KRON
1,542,954
$5.6m0.31%
0.31%
Unchanged Shares held: Q3 2021 1.3m, Q4 2021 1.5m, Q1 2022 1.5m, Q2 2022 1.5m
53
DESIGN THERAPEUTICS INC
COM
DSGN
DSGN
400,000
$5.6m0.31%
0.31%
Unchanged Shares held: Q3 2021 400.0k, Q4 2021 400.0k, Q1 2022 400.0k, Q2 2022 400.0k
54
OVID THERAPEUTICS INC
COM
OVID
OVID
2,500,000
$5.4m0.30%
0.30%
Unchanged Shares held: Q3 2021 2.5m, Q4 2021 2.5m, Q1 2022 2.5m, Q2 2022 2.5m
55
OATLY GROUP AB
SPONSORED ADS
SPONSORED ADS
1,500,000
$5.2m0.29%
0.29%
Unchanged Shares held: Q3 2021 1.5m, Q4 2021 1.5m, Q1 2022 1.5m, Q2 2022 1.5m
56
SQZ BIOTECHNOLOGIES CO
COM
SQZB
SQZB
1,606,309
$5.1m0.28%
0.28%
Unchanged Shares held: Q3 2021 1.6m, Q4 2021 1.6m, Q1 2022 1.6m, Q2 2022 1.6m
57
ALPINE IMMUNE SCIENCES INC
COM
NVLS
NVLS
593,030
$5.0m0.28%
0.28%
Unchanged Shares held: Q3 2021 593.0k, Q4 2021 593.0k, Q1 2022 593.0k, Q2 2022 593.0k
58
MARINUS PHARMACEUTICALS INC
COM NEW
MRNS
MRNS
1,000,000
$4.8m0.27%
0.27%
Unchanged Shares held: Q3 2021 1.0m, Q4 2021 1.0m, Q1 2022 1.0m, Q2 2022 1.0m
59
CONTRAFECT CORP
COM NEW
CFRX
CFRX
1,500,000
$4.6m0.26%
0.26%
Unchanged Shares held: Q3 2021 1.5m, Q4 2021 1.5m, Q1 2022 1.5m, Q2 2022 1.5m
60
LEAP THERAPEUTICS INC
COM
LPTX
LPTX
4,000,000
$4.6m0.26%
0.26%
Unchanged Shares held: Q3 2021 4.0m, Q4 2021 4.0m, Q1 2022 4.0m, Q2 2022 4.0m
61
LYELL IMMUNOPHARMA INC
COM
COM
700,000
$4.6m0.25%
0.25%
Unchanged Shares held: Q3 2021 700.0k, Q4 2021 700.0k, Q1 2022 700.0k, Q2 2022 700.0k
62
BLACK DIAMOND THERAPEUTICS I
COM
BDTX
BDTX
1,646,517
$4.0m0.23%
0.23%
Unchanged Shares held: Q3 2021 1.6m, Q4 2021 1.6m, Q1 2022 1.6m, Q2 2022 1.6m
63
ALX ONCOLOGY HLDGS INC
COM
ALXO
ALXO
500,000
$4.0m0.22%
0.22%
Unchanged Shares held: Q3 2021 500.0k, Q4 2021 500.0k, Q1 2022 500.0k, Q2 2022 500.0k
64
TAYSHA GENE THERAPIES INC
COM SHS
TSHA
TSHA
1,040,882
$3.9m0.22%
0.22%
Unchanged Shares held: Q3 2021 1.0m, Q4 2021 1.0m, Q1 2022 1.0m, Q2 2022 1.0m
65
SYROS PHARMACEUTICALS INC
COM
SYRS
SYRS
4,000,000
$3.9m0.21%
0.21%
Added Shares held: Q3 2021 2.0m, Q4 2021 3.0m, Q1 2022 3.5m, Q2 2022 4.0m
+500.0k
+500,000
14.3%
66
SEA LTD
SPONSORD ADS
SE
SE
57,500
$3.8m0.21%
0.21%
Unchanged Shares held: Q3 2021 0, Q4 2021 0, Q1 2022 57.5k, Q2 2022 57.5k
67
NANOBIOTIX
SPONSORED ADS
NBTX
NBTX
1,000,000
$3.8m0.21%
0.21%
Unchanged Shares held: Q3 2021 1.0m, Q4 2021 1.0m, Q1 2022 1.0m, Q2 2022 1.0m
68
PORTAGE FINTECH ACQUISITN CO
CLASS A ORD SHS
PFTA
PFTA
380,000
$3.7m0.21%
0.21%
Unchanged Shares held: Q3 2021 380.0k, Q4 2021 380.0k, Q1 2022 380.0k, Q2 2022 380.0k
69
RECURSION PHARMACEUTICALS IN
CL A
RXRX
RXRX
450,000
$3.7m0.20%
0.20%
Unchanged Shares held: Q3 2021 200.0k, Q4 2021 200.0k, Q1 2022 450.0k, Q2 2022 450.0k
70
AVIDITY BIOSCIENCES INC
COM
RNA
RNA
250,000
$3.6m0.20%
0.20%
Unchanged Shares held: Q3 2021 142.5k, Q4 2021 250.0k, Q1 2022 250.0k, Q2 2022 250.0k
71
AC IMMUNE SA
SHS
ACIU
ACIU
1,000,000
$3.6m0.20%
0.20%
Unchanged Shares held: Q3 2021 1.0m, Q4 2021 1.0m, Q1 2022 1.0m, Q2 2022 1.0m
72
DYNE THERAPEUTICS INC
COM
DYN
DYN
525,000
$3.6m0.20%
0.20%
Unchanged Shares held: Q3 2021 525.0k, Q4 2021 525.0k, Q1 2022 525.0k, Q2 2022 525.0k
73
ADVERUM BIOTECHNOLOGIES INC
COM
COM
3,000,000
$3.6m0.20%
0.20%
Unchanged Shares held: Q3 2021 3.0m, Q4 2021 3.0m, Q1 2022 3.0m, Q2 2022 3.0m
74
APTINYX INC
COM
COM
6,116,493
$3.4m0.19%
0.19%
Unchanged Shares held: Q3 2021 6.1m, Q4 2021 6.1m, Q1 2022 6.1m, Q2 2022 6.1m
75
STOKE THERAPEUTICS INC
COM
STOK
STOK
250,000
$3.3m0.18%
0.18%
Unchanged Shares held: Q3 2021 250.0k, Q4 2021 250.0k, Q1 2022 250.0k, Q2 2022 250.0k
76
INVIVYD INC
COM
IVVD
IVVD
1,000,000
$3.3m0.18%
0.18%
Unchanged Shares held: Q3 2021 0, Q4 2021 0, Q1 2022 1.0m, Q2 2022 1.0m
77
CULLINAN THERAPEUTICS INC
COM
CGEM
CGEM
250,000
$3.2m0.18%
0.18%
Unchanged Shares held: Q3 2021 100.0k, Q4 2021 250.0k, Q1 2022 250.0k, Q2 2022 250.0k
78
RUBIUS THERAPEUTICS INC
COM
RUBY
RUBY
3,701,580
$3.1m0.18%
0.18%
Unchanged Shares held: Q3 2021 4.2m, Q4 2021 3.7m, Q1 2022 3.7m, Q2 2022 3.7m
79
HOOKIPA PHARMA INC
COM
COM
1,849,616
$3.0m0.17%
0.17%
Unchanged Shares held: Q3 2021 599.6k, Q4 2021 599.6k, Q1 2022 1.8m, Q2 2022 1.8m
80
PRAXIS PRECISION MEDICINES I
COM
COM
1,200,000
$2.9m0.16%
0.16%
Unchanged Shares held: Q3 2021 1.2m, Q4 2021 1.2m, Q1 2022 1.2m, Q2 2022 1.2m
81
VIGIL NEUROSCIENCE INC
COM
VIGL
VIGL
1,121,191
$2.9m0.16%
0.16%
Unchanged Shares held: Q3 2021 0, Q4 2021 0, Q1 2022 1.1m, Q2 2022 1.1m
82
MIRION TECHNOLOGIES INC
COM CL A
MIR
MIR
500,000
$2.9m0.16%
0.16%
Unchanged Shares held: Q3 2021 0, Q4 2021 500.0k, Q1 2022 500.0k, Q2 2022 500.0k
83
VOR BIOPHARMA INC
COM
COM
550,000
$2.7m0.15%
0.15%
Unchanged Shares held: Q3 2021 550.0k, Q4 2021 550.0k, Q1 2022 550.0k, Q2 2022 550.0k
84
CINCOR PHARMA INC
COM
COM
137,010
$2.6m0.14%
0.14%
New Shares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 137.0k
85
SANA BIOTECHNOLOGY INC
COM
SANA
SANA
400,000
$2.6m0.14%
0.14%
Unchanged Shares held: Q3 2021 400.0k, Q4 2021 400.0k, Q1 2022 400.0k, Q2 2022 400.0k
86
IMMUNIC INC
COM
COM
700,000
$2.4m0.14%
0.14%
Unchanged Shares held: Q3 2021 700.0k, Q4 2021 700.0k, Q1 2022 700.0k, Q2 2022 700.0k
87
ZYMEWORKS INC
COM
ZYME
ZYME
450,000
$2.4m0.13%
0.13%
Unchanged Shares held: Q3 2021 450.0k, Q4 2021 450.0k, Q1 2022 450.0k, Q2 2022 450.0k
88
BRIDGEBIO PHARMA INC
COM
BBIO
BBIO
250,000
$2.3m0.13%
0.13%
Unchanged Shares held: Q3 2021 250.0k, Q4 2021 250.0k, Q1 2022 250.0k, Q2 2022 250.0k
89
TCR2 THERAPEUTICS INC
COM
TCRR
TCRR
750,000
$2.2m0.12%
0.12%
Unchanged Shares held: Q3 2021 750.0k, Q4 2021 750.0k, Q1 2022 750.0k, Q2 2022 750.0k
90
INSTIL BIO INC
COM
COM
450,000
$2.1m0.12%
0.12%
Unchanged Shares held: Q3 2021 450.0k, Q4 2021 450.0k, Q1 2022 450.0k, Q2 2022 450.0k
91
SENTI BIOSCIENCES INC
COM
COM
1,055,555
$2.1m0.12%
0.12%
New Shares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 1.1m
92
ADAGENE INC
ADS
ADAG
ADAG
1,000,000
$2.1m0.11%
0.11%
Unchanged Shares held: Q3 2021 1.0m, Q4 2021 1.0m, Q1 2022 1.0m, Q2 2022 1.0m
93
IMMUTEP LTD
SPONSORED ADS
SPONSORED ADS
1,000,000
$2.0m0.11%
0.11%
Unchanged Shares held: Q3 2021 1.0m, Q4 2021 1.0m, Q1 2022 1.0m, Q2 2022 1.0m
94
111 INC
ADS
ADS
966,349
$2.0m0.11%
0.11%
Unchanged Shares held: Q3 2021 966.3k, Q4 2021 966.3k, Q1 2022 966.3k, Q2 2022 966.3k
95
NEXIMMUNE INC
COM
COM
1,200,000
$1.9m0.11%
0.11%
Unchanged Shares held: Q3 2021 1.2m, Q4 2021 1.2m, Q1 2022 1.2m, Q2 2022 1.2m
96
GRAPHITE BIO INC
COM
GRPH
GRPH
700,000
$1.9m0.11%
0.11%
Unchanged Shares held: Q3 2021 700.0k, Q4 2021 700.0k, Q1 2022 700.0k, Q2 2022 700.0k
97
HARPOON THERAPEUTICS INC
COM
COM
1,000,000
$1.9m0.11%
0.11%
Unchanged Shares held: Q3 2021 1.0m, Q4 2021 1.0m, Q1 2022 1.0m, Q2 2022 1.0m
98
FUSION PHARMACEUTICALS INC
COM
COM
750,000
$1.9m0.10%
0.10%
Unchanged Shares held: Q3 2021 750.0k, Q4 2021 750.0k, Q1 2022 750.0k, Q2 2022 750.0k
99
SOLID BIOSCIENCES INC
COM
COM
3,000,000
$1.8m0.10%
0.10%
Unchanged Shares held: Q3 2021 3.0m, Q4 2021 3.0m, Q1 2022 3.0m, Q2 2022 3.0m
100
GRITSTONE BIO INC
COM
GRTS
GRTS
750,000
$1.8m0.10%
0.10%
Unchanged Shares held: Q3 2021 0, Q4 2021 750.0k, Q1 2022 750.0k, Q2 2022 750.0k